Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Stopping imipramine reduced the woman's hair loss.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Early-stage Alopecia Areata was effectively treated in less than six months.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Both treatments for localized alopecia areata are equally effective.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to safety and ease of use.

Cryotherapy may help hair regrowth in alopecia areata with possibly lower relapse rates than steroids.

Keloid scars can form after hair transplant surgery and should be prevented and treated early.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.